Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
D000368:Aged; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000235:genetics* / Q000503:physiopathology*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics*; D001921:Brain / Q000378:metabolism*; D016022:Case-Control Studies; D005260:Female; D019788:Fluorodeoxyglucose F18; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D008297:Male; D010641:Phenotype; D019275:Radiopharmaceuticals; D012720:Severity of Illness Index; D014055:Tomography, Emission-Computed
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005947:Glucose